Literature DB >> 14718093

Pulmonary tuberculosis due to Mycobacterium bovis subsp. caprae in captive Siberian tiger.

Akos Lantos1, Stefan Niemann, Lásló Mezõsi, Endre Sós, Károly Erdélyi, Sándor Dávid, Linda M Parsons, Tanja Kubica, Sabine Rüsch-Gerdes, Akos Somoskövi.   

Abstract

We report the first case of pulmonary tuberculosis caused by Mycobacterium bovis subsp. caprae in a captive Siberian tiger, an endangered feline. The pathogen was isolated from a tracheal aspirate obtained by bronchoscopy. This procedure provided a reliable in vivo diagnostic method in conjunction with conventional and molecular tests for the detection of mycobacteria.

Entities:  

Mesh:

Year:  2003        PMID: 14718093      PMCID: PMC3035528          DOI: 10.3201/eid0911.030297

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Mycobacterium bovis, a member of the M. tuberculosis complex (MTBC), can cause tuberculosis in a wide range of domestic and wild animals and also in humans (,). Routine differentiation of M. bovis is based on a number of phenotypic characteristics and biochemical tests (). M. bovis shows dysgonic growth on Löwenstein-Jensen (LJ) medium and has been described as negative for nitrate reduction and niacin accumulation (). As a further criterion for the differentiation of M. bovis, intrinsic resistance to pyrazinamide (PZA) has been described (). However, more recently, PZA-susceptible strains of M. bovis were found in Spain and Germany; these strains were also characterized by specific molecular techniques (–). As a consequence, M. bovis was split into two subspecies: M. bovis subsp. bovis, which showed resistance to PZA, and M. bovis subsp. caprae, which was sensitive to PZA (,). M. bovis subsp. caprae was initially isolated from sheep and goats in Spain (,,); however, further studies confirm its infectivity in humans, cattle, and red deer (,). We report the unusual case of a M. bovis subsp. caprae infection in a captive Siberian tiger.

Case Report

An 8-year-old male Siberian tiger at the Budapest Zoological and Botanical Garden had episodes of coughing in October 2001. Because the coughing did not stop in 6 to 7 days, an expectorant (Bisolvon; Boehringer Ingelheim Vetmed Gmbh., Ingelheim am Rhein, Germany) was given for 10 days. His condition showed a temporary improvement; however, after a few weeks, the animal started coughing again, and his appetite decreased. Amoxicillin plus clavulanic acid (Amoksiklav; Lek Animal Health, Ljubljana, Slovenia) and ketoprophen (Ketofen, Merial, Lyons, France) therapy was given for 7 days. The tiger’s condition did not show any notable improvement. In addition, in May 2002, the animal’s respiratory rate became elevated, he became dyspneic and emaciated, and his daily activity substantially decreased. Further antibacterial treatment was administered (cefatroxil, Cefa-cure; Intervet, Boxmeer, the Netherlands) during that month without clinical effect. At that point, the animal was anesthetized, and tracheoscopy was performed with a flexible 56-cm bronchoscope (Olympus B3R; Tokyo, Japan (Figure 1). The examination found a large amount of purulent mucus in the trachea. Therefore, several tracheal washings were taken for microbiologic tests by using a commercially available tracheal suction set (Medinorm Medizintechnik GmbH, Quierschied, Germany (Figure 1). A chest radiograph showed a severe and extensive bronchointerstitial pattern with cavernous lesions in both lungs.
Figure 1

Obtaining a tracheal washing of the Siberian tiger by bronchoscopy.

Obtaining a tracheal washing of the Siberian tiger by bronchoscopy. Nine days after the specimens were taken, cultures for mycobacteria showed growth in the broth-based MGIT 960 system (Becton-Dickinson Microbiology Systems, Sparks, MD). The acid-fast organism that was isolated was identified as MTBC by the AccuProbe TB assay (Gen-Probe Inc., San Diego, CA). Since the tiger had stopped eating and his condition had dramatically deteriorated, the animal was euthanized and necropsy was performed. Hematoxylin and eosin–stained histologic sections of the lung segments showed an extensive multifocal infiltration of lymphocytes, histiocytes, and some scattered multinuclear giant cells within the framework of proliferated connective tissue and collagen fibers of the cavernous lesions. Ziehl-Neelsen staining showed an intracellular accumulation of acid-fast bacteria in several alveolar macrophages and epithelioid cells. The keepers of the tiger also underwent pulmonary radiographs and tuberculin skin testing. Their skin test results were negative, and clinical or radiologic signs of tuberculosis were not detected.

Characterization of MTBC Isolate

Colony morphology of the isolated MTBC strain showed dysgonic growth on LJ medium and microaerophilic growth on Lebek medium. The strain was susceptible to PZA (100 μg/mL) and thiophen-2-carboxylic acid hydrazide (TCH; 1 μg/mL) and negative for niacin accumulation and nitrate reduction (–). The genome of the isolate was analyzed for specific mutations in the pncA, oxyR, and gyrB genes by automated DNA sequencing, polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) technique, and spoligotyping as described previously (,–). Susceptibility of the isolate to PZA was linked with a wild-type pncA sequence. In addition, the isolate contained the M. bovis–specific G-to-A mutation at position 285 in the oxyR gene and the G-to-A mutation at position 756 in the gyrB gene. However, spoligotyping showed a pattern with the absence of spacer sequences 39–43 and 3–16 (Figure 2), and T to G mutation at position 1,311 in the gyrB gene, characteristic of M. bovis subsp. caprae, could also be detected by DNA sequencing. On the basis of these phenotypic and genetic characteristics, the strain was identified as M. bovis subsp. caprae (,,,).
Figure 2

Spoligotype patterns of the isolate obtained from the Siberian tiger: lane 1; spacer sequences 3–16 and 39–43 are absent); lane 2, control strain Mycobacterium tuberculosis H37Rv ATCC 27294; lane 3, control strain M. bovis ATCC 19210; lane 4, M. bovis BCG ATCC 27289.

Spoligotype patterns of the isolate obtained from the Siberian tiger: lane 1; spacer sequences 3–16 and 39–43 are absent); lane 2, control strain Mycobacterium tuberculosis H37Rv ATCC 27294; lane 3, control strain M. bovis ATCC 19210; lane 4, M. bovis BCG ATCC 27289.

Conclusions

MTBC comprises these closely related organisms: M. tuberculosis; M. africanum; M. bovis; the vaccine strain, M. bovis bacillus Calmette-Guérin; and three rarely seen members, M. microti, M. canettii, and the recently described seal bacillus, M. pinnipedii (–). Differentiation within MTBC is necessary for individual patient treatment (i.e., inclusion or exclusion of PZA) and for epidemiologic purposes, especially in areas of the world where tuberculosis has reached epidemic proportions or wherever the transmission of M. bovis between animals, animal products, and humans is a problem (). The host range of M. bovis is wide, including many animal species and humans. Carnivores such as large felines may acquire the infection through the alimentary tract by eating infected meat (). Reports of tuberculosis in large captive or free-living felines are not common (–), however. To our knowledge, this case is the first in which tuberculosis attributable to M. bovis subsp. caprae was diagnosed in a large feline. The rapid and accurate in vivo diagnosis of tuberculosis is indispensable in endangered captive animals such as the Siberian tiger, not only because of the declining population of this species but also to prevent the transmission of the disease to other animals. Although nasal or throat swabs are used most often, we found tracheal washing by bronchoscopy was easy to perform, rapid, and more adequate than swabs (provided a larger sample volume from the lower airways) for obtaining clinical specimen for mycobacterial or other microbiologic tests. The rapid diagnosis of tuberculosis is essential for adequate antituberculosis treatment to be started as early as possible. The effectiveness of antituberculosis therapy in felines is controversial (). However, when an endangered animal is involved, early diagnosis of the disease might help control it in time to save the animal, especially with the help of a rapid in vivo diagnostic method such as tracheal washing through bronchoscopy. Tracheal washing can also be the method of choice to bacteriologically monitor the efficacy of therapy. In this case, the poor appetite and condition of the animal did not allow survival long enough for delivery of antituberculosis treatment. The source of infection could not be conclusively identified retrospectively; infected goat meat (a usual diet of the animal) is a likely possibility because the tuberculosis-related control measures are not as strict with goats as with cattle in Hungary (annual tuberculin skin testing of goats is not mandatory, for example) (). This report indicates that routine differentiation within the MTBC is indispensable for understanding the epidemiology of tuberculosis and for determining the prevalence, transmission, and clinical importance of the different members of the complex.
  25 in total

1.  Diagnosis of tuberculosis in two snow leopards using polymerase chain reaction.

Authors:  R G Helman; W C Russell; A Jenny; J Miller; J Payeur
Journal:  J Vet Diagn Invest       Date:  1998-01       Impact factor: 1.279

2.  Differentiation of phylogenetically related slowly growing mycobacteria by their gyrB sequences.

Authors:  H Kasai; T Ezaki; S Harayama
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Differentiation among members of the Mycobacterium tuberculosis complex by molecular and biochemical features: evidence for two pyrazinamide-susceptible subtypes of M. bovis.

Authors:  S Niemann; E Richter; S Rüsch-Gerdes
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Spacer oligonucleotide typing of Mycobacterium bovis strains from cattle and other animals: a tool for studying epidemiology of tuberculosis.

Authors:  A Aranaz; E Liébana; A Mateos; L Dominguez; D Vidal; M Domingo; O Gonzolez; E F Rodriguez-Ferri; A E Bunschoten; J D Van Embden; D Cousins
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

5.  Mycobacterium tuberculosis subsp. caprae subsp. nov.: a taxonomic study of a new member of the Mycobacterium tuberculosis complex isolated from goats in Spain.

Authors:  A Aranaz; E Liébana; E Gómez-Mampaso; J C Galán; D Cousins; A Ortega; J Blázquez; F Baquero; A Mateos; G Súarez; L Domínguez
Journal:  Int J Syst Bacteriol       Date:  1999-07

6.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

7.  Tuberculosis in buffaloes (Syncerus caffer) in the Kruger National Park: spread of the disease to other species.

Authors:  D F Keet; N P Kriek; M L Penrith; A Michel; H Huchzermeyer
Journal:  Onderstepoort J Vet Res       Date:  1996-09       Impact factor: 1.792

8.  A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa.

Authors:  D van Soolingen; T Hoogenboezem; P E de Haas; P W Hermans; M A Koedam; K S Teppema; P J Brennan; G S Besra; F Portaels; J Top; L M Schouls; J D van Embden
Journal:  Int J Syst Bacteriol       Date:  1997-10

Review 9.  The epidemiology of Mycobacterium bovis infections in animals and man: a review.

Authors:  L M O'Reilly; C J Daborn
Journal:  Tuber Lung Dis       Date:  1995-08

10.  [Determination of different optimal oxygen concentrations in the human & bovine Mycobacterium tuberculosis; contribution to the type determination of tubercle bacilli with mammalian pathogenicity].

Authors:  G LEBEK
Journal:  Zentralbl Bakteriol Orig       Date:  1958-12
View more
  1 in total

1.  Direct comparison of the genotype MTBC and genomic deletion assays in terms of ability to distinguish between members of the Mycobacterium tuberculosis complex in clinical isolates and in clinical specimens.

Authors:  Akos Somoskovi; Jillian Dormandy; Jeremy Rivenburg; Maria Pedrosa; Melinda McBride; Max Salfinger
Journal:  J Clin Microbiol       Date:  2008-03-19       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.